Industry Experts - Market Research Reports, Industry Analysis, Custom Research

  Overview Biopharmaceuticals, or biologics, are advanced drugs derived from living organisms such as bacteria, yeast, or mammalian cells using cutting-edge biotechnology, including recombinant DNA technology. Unlike traditional small-molecule drugs, these complex and large-molecule therapies include proteins, nucleic acids, and vaccines designed to treat chronic, complex, and rare diseases. Biopharmaceuticals play a critical role in oncology, autoimmune diseases, diabetes, inflammatory and infectious diseases, neurological disorders, cardiovascular conditions, and blood disorders . Key biopharmaceutical products include: Monoclonal antibodies for cancer and autoimmune diseases Erythropoietin (EPO) for anemia management Recombinant insulin for diabetes G-CSF to boost white blood cell production Interferons for viral infections Human growth hormones (HGH) for growth deficiencies These therapies enable gene and enzyme replacement solutions, offering precise, targeted treatme...

Industry Experts, Inc. published an updated 2019 version of the global market report on Biopharmaceuticals. As per the new report entitled " Biopharmaceuticals – A Global Market Overview ", Oncology constitutes the largest, as also the fastest, growing application for Biopharmaceuticals globally, which is expected to register a CAGR of 10.6% over 2018-2025. The biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases like cancer, HIV/AIDS and diabetes, and increase in adoption of biopharmaceuticals globally. Biopharmaceuticals offer several benefits including highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms, which have significantly increased the demand for biopharmaceutical products. The market growth is attributed to the growing acceptance for biopharmaceuticals due to their ability to treat previously unt...

Industry Experts, a multi industry focused market research firm, has unveiled the 2013 version of ‘ Biopharmaceuticals – A Global Market Overview ’. As per the new report monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In addition, monoclonal antibodies (moAb) are forecasted to record fastest growth in reaching US$138.8 billion by 2020 at a 2010-20 CAGR of 14.9%. The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in the pharmaceutical industry, which include the big pharma companies as also generic drug manufacturers, who are also engaged in developing biosimilars. In conjunction with the traditional small biopharmaceutical companies, the new bigger entrants have been focused on continually expan...